Oncternal Therapeutics Stock Price on May 2, 2024
| ONCT Stock | USD 0.71 0.43 37.72% |
Below is the normalized historical share price chart for Oncternal Therapeutics extending back to February 03, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncternal Therapeutics stands at 0.71, as last reported on the 26th of November, with the highest price reaching 0.84 and the lowest price hitting 0.62 during the day.
If you're considering investing in Oncternal Stock, it is important to understand the factors that can impact its price. Oncternal Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15% return per unit of risk over the last 3 months. Oncternal Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncternal Therapeutics' Risk Adjusted Performance of (0.09), variance of 127.32, and Coefficient Of Variation of (812.74) to confirm the risk estimate we provide.
At this time, Oncternal Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 3.1 M in 2024, whereas Common Stock is likely to drop 2,850 in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.05 in 2024, whereas Price To Sales Ratio is likely to drop 38.14 in 2024. Oncternal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2004 | 200 Day MA 6.0423 | 50 Day MA 1.374 | Beta 1.33 |
Oncternal |
Sharpe Ratio = -0.1478
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ONCT |
Estimated Market Risk
| 12.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.83 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oncternal Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncternal Therapeutics by adding Oncternal Therapeutics to a well-diversified portfolio.
Price Book 0.3688 | Enterprise Value Ebitda 0.1466 | Price Sales 1.5613 | Shares Float 2.7 M | Wall Street Target Price 2 |
Related Headline
Pasithea Therapeutics Headline on 2nd of May 2024
Acquisition by Tiago Marques of 200000 shares of Pasithea Th... by Tiago Marques
Filed transaction by Pasithea Therapeutics Corp Director, Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Oncternal Therapeutics Valuation on May 2, 2024
It is possible to determine the worth of Oncternal Therapeutics on a given historical date. On May 2, 2024 Oncternal was worth 8.0 at the beginning of the trading date compared to the closed value of 8.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncternal Therapeutics stock. Still, in general, we apply an absolute valuation method to find Oncternal Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncternal Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncternal Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.11 | 8.38 | 8.03 | 8.25 | 4,461 | |
05/02/2024 | 8.00 | 8.80 | 7.98 | 8.74 | 10,172 |
| 8.74 | 8.74 | 8.74 | 8.74 | 337.00 |
| Backtest Oncternal Therapeutics | | | Oncternal Therapeutics History | | | Oncternal Therapeutics Valuation | Previous | Next |
Oncternal Therapeutics Trading Date Momentum on May 2, 2024
| On May 03 2024 Oncternal Therapeutics was traded for 8.74 at the closing time. The top price for the day was 8.74 and the lowest listed price was 8.74 . The trading volume for the day was 337. The trading history from May 3, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.92% . |
Oncternal Therapeutics Fundamentals Correlations and Trends
By evaluating Oncternal Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncternal Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncternal financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncternal Therapeutics Stock history
Oncternal Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncternal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncternal Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncternal Therapeutics stock prices may prove useful in developing a viable investing in Oncternal Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.9 M | 3.1 M | |
| Net Loss | -50.8 M | -53.3 M |
Oncternal Therapeutics Quarterly Net Working Capital |
|
Oncternal Therapeutics Stock Technical Analysis
Oncternal Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oncternal Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Oncternal Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncternal Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns
Oncternal Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncternal Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Oncternal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncternal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.33) | |||
| Total Risk Alpha | (3.18) | |||
| Treynor Ratio | 2.46 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Oncternal Stock Analysis
When running Oncternal Therapeutics' price analysis, check to measure Oncternal Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncternal Therapeutics is operating at the current time. Most of Oncternal Therapeutics' value examination focuses on studying past and present price action to predict the probability of Oncternal Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncternal Therapeutics' price. Additionally, you may evaluate how the addition of Oncternal Therapeutics to your portfolios can decrease your overall portfolio volatility.